Phase II Trial of Carboplatin, Weekly Paclitaxel and Biweekly Bevacizumab in Patients with Unresectable Stage IV Melanoma – A North Central Cancer Treatment Group (NCCTG) Study, N047A1
- Citation:
- Cancer vol 115 (1) 119-127
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 652
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- U10 CA035267, M01 RR000585, U10 CA052352, N01 CA035431, U10 CA035269, M01 RR000585-332026, CA-35090, U10 CA060276, CA-52352, CA-35195, M01 RR000585-332075, U10 CA035195, CA-35103, CA-25224, CA-60276, U10 CA035101, U10 CA063849, M01 RR000585-342075, U10 CA035431, CA-35269, CA-35101, U10 CA025224, U10 CA035090, CA-35267, CA-63849, U10 CA035103
- Corr. Author:
- Authors:
- Domingo G. Perez Vera J. Suman Tom R. Fitch Thomas Amatruda Roscoe F. Morton Shamim Z. Jilani Costas L. Constantinou James R. Egner Lisa A. Kottschade Svetomir N. Markovic
- Networks:
- Study
- NCCTG-N047A
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Metastatic melanoma, angiogenesis, chemotherapy, phase II trials